{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T02:48:29Z","timestamp":1790563709430,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.biopha.2025.118223","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T17:41:07Z","timestamp":1748886067000},"page":"118223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Antimicrobial profile of new pyrazole-based alkanoyl and oxoalkyl analogues of ciprofloxacin"],"prefix":"10.1016","volume":"188","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3269-9672","authenticated-orcid":false,"given":"Anna","family":"Bielenica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9793-5248","authenticated-orcid":false,"given":"Piotr","family":"Roszkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela Anna","family":"Hryciuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Stefa\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2117-0100","authenticated-orcid":false,"given":"Kinga","family":"Markowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9036-7452","authenticated-orcid":false,"given":"Anna","family":"Majewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Koli\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7623-0935","authenticated-orcid":false,"given":"Sebastian","family":"Kmiecik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6928-4561","authenticated-orcid":false,"given":"Alicja","family":"Chrzanowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Struga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8057","key":"10.1016\/j.biopha.2025.118223_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/d41586-025-00945-z","article-title":"New antibiotic that kills drug-resistant bacteria discovered in technician's garden","volume":"640","author":"Mallapaty","year":"2025","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.biopha.2025.118223_bib2","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41570-021-00313-1","article-title":"Towards the sustainable discovery and development of new antibiotics","volume":"5","author":"Miethke","year":"2021","journal-title":"Nat. Rev. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2025.118223_bib3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jhet.3045","article-title":"4-formyl-pyrazole-3-carboxylate: a useful Aldo-X bifunctional precursor for the syntheses of pyrazole-fused\/substituted frameworks","volume":"55","author":"Devi","year":"2018","journal-title":"J. Heterocycl. Chem."},{"issue":"11","key":"10.1016\/j.biopha.2025.118223_bib4","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1039\/D2MD00206J","article-title":"Pyrazole-containing pharmaceuticals: target, pharmacological activity, and their SAR studies","volume":"13","author":"Li","year":"2022","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.biopha.2025.118223_bib5","article-title":"Exploring the antimicrobial potential of novel 1,2,4-triazole conjugates with pyrazole: synthesis, biological activity and in silico docking","author":"Kolukula","year":"2024","journal-title":"Chem. Biodivers."},{"issue":"1","key":"10.1016\/j.biopha.2025.118223_bib6","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1080\/14756366.2020.1791842","article-title":"Novel heterocyclic hybrids of pyrazole targeting dihydrofolate reductase: design, biological evaluation and in silico studies","volume":"35","author":"Othman","year":"2020","journal-title":"J. Enzym. Inhib. Med Chem."},{"issue":"8","key":"10.1016\/j.biopha.2025.118223_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25081909","article-title":"A review on recent advances in nitrogen-containing molecules and their biological applications","volume":"25","author":"Kerru","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2025.118223_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107761","article-title":"Discovery of new molecular hybrid derivatives with coumarin scaffold bearing pyrazole\/oxadiazole moieties: molecular docking, POM analyses, pharmacokinetics and antimicrobial evaluation with identification of potent antitumor pharmacophore sites","volume":"153","author":"Tataringa","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"8","key":"10.1016\/j.biopha.2025.118223_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300110","article-title":"Synthesis and antimicrobial activity evaluation of pyrazole derivatives containing the imidazo[2,1-][1,3,4]thiadiazole moiety","volume":"356","author":"Qi","year":"2023","journal-title":"Archiv Der Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2025.118223_bib10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/cbdd.13632","article-title":"New library of pyrazole-imidazo[1,2-\u03b1]pyridine molecular conjugates: Synthesis, antibacterial activity and molecular docking studies","volume":"95","author":"Ebenezer","year":"2020","journal-title":"Chem. Biol. Drug Des."},{"issue":"3","key":"10.1016\/j.biopha.2025.118223_bib11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s40265-021-01475-4","article-title":"Berotralstat: first approval","volume":"81","author":"Lee","year":"2021","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.biopha.2025.118223_bib12","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1021\/acs.jmedchem.6b00990","article-title":"Structural basis for potency and promiscuity in poly(ADP-ribose) polymerase (PARP) and Tankyrase inhibitors","volume":"60","author":"Thorsell","year":"2017","journal-title":"J. Med Chem."},{"issue":"3","key":"10.1016\/j.biopha.2025.118223_bib13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1124\/mol.116.107037","article-title":"Ability of Bruton's Tyrosine kinase inhibitors to Sequester Y551 and prevent phosphorylation determines potency for inhibition of Fc receptor but not B-cell receptor signaling","volume":"91","author":"Bender","year":"2017","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2025.118223_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.clml.2019.11.010","article-title":"Elevated white blood cell levels and thrombotic events in patients with polycythemia vera: a real-world analysis of veterans health administration data","volume":"20","author":"Parasuraman","year":"2020","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"6","key":"10.1016\/j.biopha.2025.118223_bib15","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s10637-019-00743-1","article-title":"Axitinib pharmacologic therapeutic monitoring reveals severe under-exposure despite titration in patients with metastatic renal cell carcinoma","volume":"37","author":"Beinse","year":"2019","journal-title":"Investig. N. Drugs"},{"key":"10.1016\/j.biopha.2025.118223_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.666725","article-title":"Heterocyclic compounds: pharmacology of pyrazole analogs from rational structural considerations","volume":"12","author":"Costa","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"16","key":"10.1016\/j.biopha.2025.118223_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612724","article-title":"Recent advances in the development of pyrazole derivatives as anticancer agents","volume":"24","author":"Zhang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118223_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40265-013-0168-2","article-title":"Ceftolozane\/tazobactam: a novel cephalosporin\/beta-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli","volume":"74","author":"Zhanel","year":"2014","journal-title":"Drugs"},{"issue":"8","key":"10.1016\/j.biopha.2025.118223_bib19","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1128\/AAC.39.8.1756","article-title":"Inhibition of recombinant pneumocystis-carinii dihydropteroate synthetase by Sulfa drugs","volume":"39","author":"Hong","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2025.118223_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104094","article-title":"Novel bis(pyrazole-benzofuran) hybrids possessing piperazine linker: synthesis of potent bacterial biofilm and MurB inhibitors","volume":"102","author":"Mekky","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2025.118223_bib21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11030-020-10046-w","article-title":"Antibacterial evaluation and molecular docking studies of pyrazole-thiosemicarbazones and their pyrazole-thiazolidinone conjugates","volume":"25","author":"Ebenezer","year":"2021","journal-title":"Mol. Divers."},{"key":"10.1016\/j.biopha.2025.118223_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106975","article-title":"Fluorinated azoles as effective weapons in fight against methicillin-resistance Staphylococcus aureus (MRSA) and its SAR studies","volume":"143","author":"Zhao","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.biopha.2025.118223_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113134","article-title":"Pyrazole-based analogs as potential antibacterial agents against methicillin-resistance Staphylococcus aureus (MRSA) and its SAR elucidation","volume":"212","author":"Verma","year":"2021","journal-title":"Eur. J. Med Chem."},{"issue":"6","key":"10.1016\/j.biopha.2025.118223_bib24","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1021\/acsomega.1c05801","article-title":"In Vitro antimicrobial evaluation, single-point resistance study, and radiosterilization of novel pyrazole incorporating thiazol-4-one\/thiophene derivatives as dual DNA gyrase and DHFR inhibitors against MDR pathogens","volume":"7","author":"Ali Mohamed","year":"2022","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.biopha.2025.118223_bib25","article-title":"Design, synthesis, molecular modeling, and antimicrobial potential of novel 3-[(1H-pyrazol-3-yl)imino]indolin-2-one derivatives as DNA gyrase inhibitors","volume":"355","author":"Alzahrani","year":"2022","journal-title":"Arch. Pharm. (Weinh. )"},{"issue":"5","key":"10.1016\/j.biopha.2025.118223_bib26","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1021\/acsmedchemlett.9b00674","article-title":"Screen of unfocused libraries identified compounds with direct or synergistic antibacterial activity","volume":"11","author":"Mugnaini","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"issue":"8","key":"10.1016\/j.biopha.2025.118223_bib27","article-title":"New pyrazolo-benzimidazole Mannich bases with antimicrobial and antibiofilm activities","volume":"11","author":"Zalaru","year":"2022","journal-title":"Antibiot. (Basel)"},{"issue":"1","key":"10.1016\/j.biopha.2025.118223_bib28","article-title":"Antibiofilm and anti-quorum-sensing activities of novel pyrazole and pyrazolo[1,5-a]pyrimidine derivatives as carbonic anhydrase I and II inhibitors: design, synthesis, radiosterilization, and molecular docking studies","volume":"12","author":"Ragab","year":"2023","journal-title":"Antibiot. (Basel)"},{"issue":"10","key":"10.1016\/j.biopha.2025.118223_bib29","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.bmcl.2019.03.020","article-title":"Thiazolyl-pyrazole derivatives as potential antimycobacterial agents","volume":"29","author":"Takate","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2025.118223_bib30","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bioorg.2019.02.044","article-title":"Structure-based design, synthesis and biological evaluation of a newer series of pyrazolo[1,5-a]pyrimidine analogues as potential anti-tubercular agents","volume":"87","author":"Modi","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2025.118223_bib31","article-title":"Synthesis, antimycobacterial, cytotoxicity, anti-inflammatory, in silico studies and molecular dynamics of pyrazole-embedded thiazolidin-4-one hybrids","volume":"356","author":"Kamat","year":"2023","journal-title":"Arch. Pharm. (Weinh. )"},{"key":"10.1016\/j.biopha.2025.118223_bib32","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ejmech.2018.01.078","article-title":"Ciprofloxacin derivatives and their antibacterial activities","volume":"146","author":"Zhang","year":"2018","journal-title":"Eur. J. Med Chem."},{"key":"10.1016\/j.biopha.2025.118223_bib33","doi-asserted-by":"crossref","first-page":"1025633","DOI":"10.3389\/fpubh.2022.1025633","article-title":"The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic","volume":"10","author":"Shariati","year":"2022","journal-title":"Front Public Health"},{"issue":"5","key":"10.1016\/j.biopha.2025.118223_bib34","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1021\/acsami.3c14357","article-title":"Ciprofloxacin poly(beta-amino ester) conjugates enhance antibiofilm activity and slow the development of resistance","volume":"16","author":"Kasza","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.biopha.2025.118223_bib35","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1039\/D4MD00623B","article-title":"Design, synthesis, and biological evaluation of pyrazole-ciprofloxacin hybrids as antibacterial and antibiofilm agents against Staphylococcus aureus","volume":"16","author":"Ommi","year":"2024","journal-title":"RSC Med Chem."},{"issue":"7","key":"10.1016\/j.biopha.2025.118223_bib36","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00706-018-2215-x","article-title":"Modifications of quinolones and fluoroquinolones: hybrid compounds and dual-action molecules","volume":"149","author":"Fedorowicz","year":"2018","journal-title":"Mon. Chem."},{"issue":"18","key":"10.1016\/j.biopha.2025.118223_bib37","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1016\/j.bmcl.2019.07.041","article-title":"Ciprofloxacin-1,2,3-triazole-isatin hybrids tethered via amide: Design, synthesis, and in vitro anti-mycobacterial activity evaluation","volume":"29","author":"Chen","year":"2019","journal-title":"Bioorg. Med Chem. Lett."},{"key":"10.1016\/j.biopha.2025.118223_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102952","article-title":"Design, synthesis and molecular docking of new N-4-piperazinyl ciprofloxacin-triazole hybrids with potential antimicrobial activity","volume":"88","author":"Mohammed","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"24","key":"10.1016\/j.biopha.2025.118223_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27248708","article-title":"Recent advancement in drug design and discovery of pyrazole biomolecules as cancer and inflammation therapeutics","volume":"27","author":"Alam","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2025.118223_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117439","article-title":"Antibacterial and anti-biofilm activities of new fluoroquinolone derivatives coupled with nitrogen-based heterocycles","volume":"179","author":"Roszkowski","year":"2024","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2025.118223_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105339","article-title":"Hydrazonoyl bromide precursors as inhibitors for the synthesis of bis-thiazolyl pyrazole derivatives; antimicrobial activities, antibiofilm, and drug combination studies against","volume":"116","author":"Ibrahim","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"13","key":"10.1016\/j.biopha.2025.118223_bib42","doi-asserted-by":"crossref","first-page":"8441","DOI":"10.1021\/acs.jmedchem.2c01866","article-title":"Design and synthesis of 4-fluorophenyl-5-methylene-2(5H)-furanone derivatives as potent quorum sensing inhibitors","volume":"66","author":"Zhang","year":"2023","journal-title":"J. Med Chem."},{"issue":"6","key":"10.1016\/j.biopha.2025.118223_bib43","doi-asserted-by":"crossref","first-page":"848","DOI":"10.2174\/1389557521666211202115259","article-title":"Quorum sensing regulation as a target for antimicrobial therapy","volume":"22","author":"Ruiz","year":"2022","journal-title":"Mini-Rev. Med. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2025.118223_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2023.116048","article-title":"Remarkable antibiofilm activity of ciprofloxacin, cefoxitin, and tobramycin, by themselves or in combination, against enteroaggregative Escherichia coli in vitro","volume":"107","author":"Gastaldi Guerrieri","year":"2023","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.biopha.2025.118223_bib45","doi-asserted-by":"crossref","first-page":"1377047","DOI":"10.3389\/fmicb.2024.1377047","article-title":"Development of an in vitro biofilm model for the study of the impact of fluoroquinolones on sewer biofilm microbiota","volume":"15","author":"Naudin","year":"2024","journal-title":"Front. Microbiol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118223_bib46","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03412-23","article-title":"Effects of sub-inhibitory concentrations of nafcillin, vancomycin, ciprofloxacin, and rifampin on biofilm formation of clinical methicillin-resistant Staphylococcus aureus","volume":"12","author":"Park","year":"2024","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.biopha.2025.118223_bib47","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8143739","article-title":"Conjugation of LasR quorum-sensing inhibitors with ciprofloxacin decreases the antibiotic tolerance of clinical strains","volume":"2019","author":"Bortolotti","year":"2019","journal-title":"J. Chem."},{"key":"10.1016\/j.biopha.2025.118223_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115373","article-title":"Antibacterial and antibiofilm activity of permanently ionized quaternary ammonium fluoroquinolones","volume":"254","author":"Fedorowicz","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"21","key":"10.1016\/j.biopha.2025.118223_bib49","doi-asserted-by":"crossref","first-page":"18663","DOI":"10.1021\/acsomega.3c00554","article-title":"N-acylated ciprofloxacin derivatives: synthesis and in vitro biological evaluation as antibacterial and anticancer agents","volume":"8","author":"Struga","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.biopha.2025.118223_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111810","article-title":"Anticancer and antimicrobial effects of novel ciprofloxacin fatty acids conjugates","volume":"185","author":"Chrzanowska","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.biopha.2025.118223_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23116261","article-title":"The effect of conjugation of ciprofloxacin and moxifloxacin with fatty acids on their antibacterial and anticancer activity","volume":"23","author":"Chrzanowska","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2025.118223_bib52","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"issue":"1-3","key":"10.1016\/j.biopha.2025.118223_bib53","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2025.118223_bib54","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/jam.12631","article-title":"Sodium ascorbate as a quorum sensing inhibitor of","volume":"117","author":"El-Mowafy","year":"2014","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.biopha.2025.118223_bib55","article-title":"CLSI. Performance standards for antimicrobial susceptibility testing. 29th ed. CLSI supplement","author":"Wayne","year":"2019","journal-title":"M100. . Clin. Lab. Stand. Inst."},{"issue":"5","key":"10.1016\/j.biopha.2025.118223_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/s41596-021-00515-3","article-title":"Microtiter plate assays to assess antibiofilm activity against bacteria","volume":"16","author":"Haney","year":"2021","journal-title":"Nat. Protoc."},{"issue":"11","key":"10.1016\/j.biopha.2025.118223_bib57","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.1021\/acs.jctc.8b00768","article-title":"Automated topology builder Version 3.0: prediction of solvation free enthalpies in water and hexane","volume":"14","author":"Stroet","year":"2018","journal-title":"J. Chem. Theory Comput."},{"issue":"7","key":"10.1016\/j.biopha.2025.118223_bib58","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1073\/pnas.1525047113","article-title":"Crystal structure and stability of gyrase-fluoroquinolone cleaved complexes from Mycobacterium tuberculosis","volume":"113","author":"Blower","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.biopha.2025.118223_bib59","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.160157","article-title":"Exploring the active site of the Streptococcus pneumoniae topoisomerase IV-DNA cleavage complex with novel 7,8-bridged fluoroquinolones","volume":"6","author":"Laponogov","year":"2016","journal-title":"Open Biol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118223_bib60","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nprot.2016.051","article-title":"Computational protein-ligand docking and virtual drug screening with the AutoDock suite","volume":"11","author":"Forli","year":"2016","journal-title":"Nat. Protoc."},{"issue":"15","key":"10.1016\/j.biopha.2025.118223_bib61","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1021\/acs.jcim.3c00658","article-title":"VMD as a platform for interactive small molecule preparation and visualization in quantum and classical simulations","volume":"63","author":"Spivak","year":"2023","journal-title":"J. Chem. Inf. Model."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225004172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225004172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T15:55:35Z","timestamp":1758124535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225004172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":61,"alternative-id":["S0753332225004172"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118223","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial profile of new pyrazole-based alkanoyl and oxoalkyl analogues of ciprofloxacin","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118223","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118223"}}